Review Committee regarding Standing Recommendations for COVID-19
The IHR Review Committee regarding Standing Recommendations for COVID-19 is convened pursuant to Articles 16, 50.1.(b) and 53 of the IHR, also considering the advice of the IHR Emergency Committee on the COVID-19 pandemic. This Review Committee is holding its first meeting on 27 July 2023.
Noting that, on 5 May 2023, the COVID-19 pandemic ceased to constitute a Public Health Emergency of International Concern, and that Temporary Recommendations, valid until 4 August 2023, were issued pursuant to Article 15 of the IHR, this Review Committee is providing its views and technical advice to the Director-General with respect to Standing Recommendations for COVID-19, as proposed by the Director-General. The Terms of Reference of this Review Committee are available here.
This Review Committee will function in accordance with the WHO Regulations for Expert Advisory Panels and Committees.
For any information about this Review Committee, please contact ihrrc@who.int.
Report of the Review Committee
During the public health emergency of international concern associated with the COVID-19 pandemic, from January 2020 to May 2023, countries’ response...
Director-General's opening remarks
Chair
Director of Surveillance, Area of Infection Control, Management and Staff, Norwegian Institute of Public Health, Norway
Vice-Chair
Manager, Public Health Strategy, Ministry of Health, New Zealand
Rapporteur
Director of Health and Social Policy, Delegation of the Spanish Government in Catalonia, Spain
Members
Undersecretary for Preventive Affairs, Ministry of Health and Population, Egypt
Executive Director, The Eastern Mediterranean Public Health Network (EMPHNET)
Chief Medical Officer, Ministry of Health and Wellness, Jamaica
Associate Researcher, Fundação Oswaldo Cruz (Fiocruz), Brasilia, Distrito Federal, Brazil
Adjunct Professor of Clinical Medicine Emory University; Retired Director, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, United States Centers for Disease Control and Prevention, USA
COVID-19 Regional Program Development Consultant/Project Director for Project HOPE in North Africa; Former Federal Minister of Health of Sudan
Assistant Professor, Law School, and Director of the Center for Global Law and Strategy, Law and Technology Institute, Renmin University of China, Beijing, China
Chief Medical Officer at Casablanca International Airport, Morocco; National Coordinator of the Points of Entry Program of Morocco
Country Director, Eastern Mediterranean Public Health Network (EMPHNET), Bangladesh Office, Dhaka, Bangladesh
Executive Director, Wits RHI, University of the Witwatersrand, Johannesburg, South Africa
Head of Health Protection, Ministry of Health and Medical Services, Suva, Fiji
Director, Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Japan
Consultant Community Physician, Quarantine Unit, Ministry of Health, Sri Lanka
Deputy Head, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), Russian Federation
Lawyer and Registered Patent Agent, New Delhi, India
Professor of Virology, Redeemer’s University, Ede, Osun State, Nigeria
Head of Influenza, Respiratory Virology & Polio Reference Services, UK Health Security Agency; Co-Director, Health Protection Research Unit in Respiratory Infections, NIHCR, Imperial College London, UK